A B S T R A C T The interaction of the human plasma protein, alpha-l-antitrypsin, with porcine pancreatic elastase was studied by isolating and characterizing their reaction products. Native alpha-l-antitrypsin has a mass ratio (Mr) of54,000, an amino-terminal glx, and a carboxy-terminal lys residue. The elastase used has an Mr-of 26,400 and an amino-terminal val residue. When the two proteins are combined at inhibitor excess, two major products resuilt. One of the products is a complex of the enzyme and inhibitor with amino-terminal ser and val residues, which indicates that a peptide has been removed from the amino-terminal end of the inhibitor. The second product is a modified form of alpha-l-antitrypsin with an Mr of 51,300, an aminoterminal glx residue and a carboxy-terminal thr-leu dipeptide. It has no inhibitory activity against elastase. The components of the isolated complex can be split at high pH in the presence of diisopropyl fluorophosphate, which results in a catalytically inactive enzyme with the same Mr and amino-terminal residue as the native enzyme, and a large fragment of alpha-lantitrypsin (alpha-l-antitrypsin*). This fragment has an Mr of 50,100, an amino-terminal ser residue and a carboxy-terminal thr-leu dipeptide. Based on these data, the following hypothesis is proposed. Elastase can attack alpha-l-antitrypsin at either oftwo major sites. If it attacks first at the carboxy side of the thr-leu dipeptide, located in the carboxy-terminal portion of the inhibitor, the alpha-l-antitrypsin is cleaved into two fragments with loss ofinhibitory activity and absence of complex formation. If, however, the elastase first attacks an x-ser bond near the amino-terminal end ofthe inhibitor, the elastase then reacts with alpha-iantitrypsin at the same leu moiety to form a stable complex with complete inhibition of the enzyme.
INTRODUCTION
Individuals who have a genetically determined low concentration of alpha-l-antitrypsin in their blood usually develop pulmonary emphysema at an early age (1) . Because alpha-l-antitrypsin is known to be a protease inhibitor (2) , emphysema in such patients might logically be attributed to the unrestrained action of an enzyme or several enzymes on pulmonary tissues (3) . Alpha-l-antitrypsin is a glycoprotein in plasma which inhibits many proteolytic enzymes. The pathologic and physiologic derangements characteristic of pulmonary emphysema can be induced in small animals by introducing proteolytic enzymes of the elastase class into their lungs. We have therefore studied the mechanism by which alpha-l-antitrypsin inhibits elastases.
Elastases are enzymes which catalyze the hydrolysis of certain peptide bonds in native elastin. These enzymes usually cleave proteins or amide or ester substrates at amino acids with small aliphatic side-chains (4) . Trypsin (5) has been shown to attack a lys-x peptide bond in alpha-l-antitrypsin; however, it then forms a stable tetrahedral or acyl complex with the inhibitor which does not hydrolyze as do similar bonds in other proteins. If elastases are inhibited by a similar mechanism, then they probably attack alpha-l-antitrypsin at a specific residue at the active site for elastase, and become tightly bound to the inhibitor. It is quite likely that all elastases inhibited by alpha-l-antitrypsin are bound to the inhibitor at the same site, which makes it reasonable to investigate the elastase inhibitory site with the most available and best characterized elastase, that derived from porcine pancreas (6) .
It would be premature to draw conclusions at this time as to which elastase, if any, causes damage to emphysematous lungs. Several enzymes with possible access to the lung include elastases from neutrophils (7, 8) , platelets (9) , and alveolar macrophages (10) .
In previous work, we (11) and others (12) have re-ported that a number of complexes of different molecular weight form between alpha-l-antitrypsin and pancreatic elastase which can be demonstrated on polyacrylamide disc-gel electropherograms in sodium dodecyl sulfate (SDS-PAG).1 In the experiments reported herein, we describe conditions under which a complex was sufficiently stable to be isolated. The enzyme and inhibitor components were then separated from each other and characterized. A preliminary report on the essential aspects of this work has been made (13) . METHODS Isolation of alpha-l-antitrypsin. We have combined the most effective steps in each of several published methods (14) (15) (16) (17) to achieve an optimal method of isolation. All purification steps were carried out at 5°C except for the thiol Sepharose 4B mixed disulfide interchange column (Pharmacia Fine Chemicals, Div. of Phamacia Inc., Piscataway, N. J.), which was operated at room temperature. All samples of alpha-lantitrypsin, elastase, and fractions obtained at selected purification steps were stored at -200C. Blood from volunteer donors known to possess alpha-l-antitrypsin of phenotype MM, collected in acid-citrate-dextrose anticoagulant, was used on the same day of collection to obtain platelet-poor plasma by differential centrifugation. Plasma not immediately used was quick-frozen and stored at -20°C until needed. Alpha-l-antitrypsin was isolated from plasma thus obtained by the procedure recently established in this laboratory (18) that involves salt precipitation, removal of albumin with insolubilized Cibacron Blue dye (Ciba-Geigy Corp., Pigments Dept., Ardsley, N. Y.), further fractionation with two different anion-exchange columns, and finally a disulfide interchange column. The purified alpha-l-antitrypsin was dialyzed extensively in Tris-HCl, 0.05 M, pH 7.5, containing sodium chloride, 0.1 M, sodium azide, 3 mM, and 2-mercaptoethanol, 1 mM.
Properties of purified alpha-l-antitrypsin. The purified alpha-l-antitrypsin in these studies inhibited an equimolar amount of active-site titrated trypsin by the pH Stat assay described below and had a single amino-terminal glx and a carboxy-terminal lys. It exhibited a single band on polyacrylamide gel electrophoresis with or without SDS, and had a phenotypic pattern on isoelectric focusing (19) identical to that of the normal phenotype MM. It formed a single immunoprecipitate in double immunodiffusion analysis with antisera against alpha-l-antitrypsin or whole serum, but did not react with antisera against human alpha-l-acid glycoprotein, albumin, antithrombin III, haptoglobin, alpha-l-antichymotrypsin, prealbumin, Gc-globulin, transferrin, interalpha-l-antitrypsin, or alpha-2-macroglobulin. By the single radial immunodiffusion technique, the starting plasma contained 320 mg, and the purified preparation 126 mg of alpha-1-antitrypsin, which represents a recovery of 39.4%.
Trypsin inhibitory capacity. The inhibitory capacity of alpha-l-antitrypsin toward trypsin was measured with the pH Stat (Radiometer Co., Copenhagen, Denmark) as described by Walsh and Wilcox (20) with sodium hydroxide, 0.1 M, as 1Abbreviations used in this paper: Ac-triAla-Me, N-acetyl-L-alanyl-L-alanyl-L-alanine methyl ester; DFP, diisopropyl fluorophosphate; Mr, mass ratios; SDS, sodium dodecyl sulfate; SDS-PAG, polyacrylamide disc-gel electropherograms in SDS.
titrant and p-tosyl-L-arginine methyl ester (Calbiochem, San Diego, Calif.) as substrate. The porcine trypsin (Miles Laboratories Inc., Elkhart, Ind.) used for this assay was first titrated for active sites with p-nitrophenyl-p-guanidino-benzoate-HCl (ICN Pharmaceuticals Inc., Cleveland, Ohio) by the method of Chase and Shaw (21) . It was found to be 85% active with this titrant. The Mr used for alpha-l-antitrypsin and trypsin were 54,000 (11) and 24,000 (22) , respectively. The purified alpha-l-antitrypsin used in these studies was capable of completely inhibiting trypsin in this assay at a calculated inhibitor to active enzyme ratio of 2.25 mg (+3%) to 1 mg. This ratio corresponds to that for equimolar amounts of inhibitor and enzyme.
Purification of elastase, titration with alpha-l-antitrypsin, and active-site titration. Elastase was isolated from an acetone powder of porcine pancreas, Trypsin 1-300 (ICN Pharmaceuticals Inc.), according to the method of Shotton (6) . The purified product was reacted with L-1-tosylamide-2-phenylethyl-chloromethyl ketone and N-a-p-tosyl-L-lysine-chloromethyl ketone-HCl (Sigma Chemical Co., St. Louis, Mo.), as previously described (11) , to destroy contaminating chymotryptic and tryptic activities. The final elastase preparation thus treated was dialyzed in Tris-HCl, 0.1 M, containing sodium azide, 3 mM, pH 7.6. Before use in the present studies, the elastase was analyzed by active-site titration (23) with p -nitrophenyl -3-(N -acetyl -L-alanyl-L-alanyl)-2-methylcarbazate, kindly provided by Dr. James C. Powers, Georgia Institute of Technology, Atlanta, Ga. By this method, the elastase was found to be 94.5% active, assuming a stoichiometric reaction with the titrant, and comparing the result with the absorbancy of the enzyme preparation at 280 nm.
The purified elastase was titrated with purified alpha-lantitrypsin in the pH Stat system described above, except that 0.02 M N-acetyl-L-alanyl-L-alanyl-L-alanine methyl ester (Ac-triAla-Me) (Calbiochem) was used'as substrate (24) . The Mr used for elastase in calculating the degree of inhibition by alpha-l-antitrypsin was 26,400 (11) .
Radioactive labeling ofelastase. Purified porcine elastase was labeled with 125I by the method of McFarlane (25) , except that the preparation of working iodine-monochloride solution contained 4.2 mg of iodine as iodine-monochloride/ ml (10 times the original concentration). The 125I-elastase had a sp act of 4.4 x 107 cpmlmg. Its catalytic activity was identical to that of the unlabeled enzyme.
Amino-terminal and carboxy-terminal analyses. Aminoterminal analysis (26) was carried out with the modifications described by Mosesson et al. (27) Immunologic and electrophoretic methods. Double immunodiffusion and immunoelectrophoresis were carried out by conventional methods (33) . Specific antisera for human alpha-l-antitrypsin, albumin, whole serum, alpha-l-antichymotrypsin, antithrombin III, alpha-2-macroglobulin, haptoglobulin, Gc-globulin, prealbumin, inter-alpha-l-antitrypsin, alpha-l-acid glycoprotein, and transferrin were obtained commercially (Behring Diagnostics, American Hoechst Corp., Sommerville, N. J.). Rabbit antiserum for porcine pancreatic elastase was produced in this laboratory. Quantitation of alpha-l-antitrypsin by single radial immunodiffusion was carried out by the method of Mancini et al. (34) . Disc-gel electrophoresis (7.5% acrylamide) was carried out in the absence (35) and presence (36) of SDS. To determine Mr, electrophoresis in polyacrylamide gels (10% acrylamide) which contained SDS was carried out after the procedure ofLaemmli (37) as modified by Hokin et al. (38) . Isoelectric focusing in acrylamide slab gels for the purpose of examining the phenotypic pattern of alpha-l-antitrypsin in plasma or purified preparations was carried out as described by Kueppers (19) . Only plasma that exhibited the staining pattern ofthe normal phenotype MM was used for purification of the inhibitor.
Miscellaneous. The 125I content ofliquid samples and polyacrylamide gel slices was determined in a Nuclear-Chicago automatic gamma spectrometer (Nuclear-Chicago Corp., Des Plaines, Ill.). Densitometric scans of stained polyacrylamide gels were carried out for absorbance at 580 nm with an ISCO model 659 densitometer (Instrumentation Specialties Co., Lincoln, Neb.). Salt gradients of ion-exchange columns were determined by measurement of the conductivity of column eluates with a Radiometer model CDM 3 conductivity meter (Radiometer Co.) and comparison with standard buffer-sodium chloride solutions.
Protein concentrations were determined by measurement of absorbance at 280 nm with the following extinction coefficients (absorbance ofa 1% solution, 1-cm light path): alpha-I-antitrypsin, 5.0 (39); elastase, 22.2 (6); trypsin, 15.0 (22) . The large fragments of alpha-l-antitrypsin which resulted from interaction with elastase, i.e., inactive alpha-l-antitrypsin and alpha-l-antitrypsin*, were calculated to have extinction coefficients of5.3 and 5.4, respectively, by comparison oftheir Mr with that of alpha-l-antitrypsin, and assuming the same content of tyrosine and tryptophan residues (11) . A calculated extinction coefficient of 12.0 for the alpha-l-antitrypsinelastase complex was derived on the basis of a 1:1 molar combination of the enzyme and inhibitor, taking into account the loss of small peptides from the inhibitor. Ion-exchange purification steps were carried out with Whatman DE-52 cellulose anion exchange resin H. Reeve Angel & Co., Inc., Clifton, N. J.). Ultrafiltration with PM10 membranes (Amicon Corp., Scientific Sys. Div., Lexington, Mass.) was used to concentrate material recovered from columns.
RESULTS
Titration of elastase with alpha-l-antitrypsin. Mix (11) , in order of increasing mobility (Fig. 2, gel A) . The sample that contained the reactants in 2:1 molar ratio also showed a low, but clearly observable, amount of protein with the mobility of free elastase, as might be expected from the results described above, and illustrated in Fig. 1 , on titration of elastase with alpha-l-antitrypsin.
Isolation and analysis of the alpha-l-antitrypsinelastase complex. Because both kinetic and electrophoretic analyses demonstrated that components ofthe interaction of alpha-l-antitrypsin and elastase are stable when combined in a molar ratio of 3:1, this ratio of reactants (30-min reaction time before addition ofDFP) FIGURE 2 SDS-Polyacrylamide gel (7.5% acrylamide) electropherograms of fractions obtained during purification of the alpha-l-antitrypsin-elastase complex (Fig. 3) . The patterns observed represent: A, alpha-l-antitrypsin and elastase in 3:1 molar combination; B, peak I; C, peak II; D, native alpha-lantitrypsin; and E, elastase. The arabic numbers to the right represent the mobility of the alpha-l-antitrypsin-elastase complex (band 1), native alpha-l-antitrypsin (band 2), inactive alpha-l-antitrypsin (band 3), and elastase (band 4). All samples contained 35 ,ug of protein, except the elastase control which contained 20 dig. Anode at bottom. was considered to provide a safe margin of inhibitory capacity for isolation of the alpha-l-antitrypsinelastase complex. Alpha-l-antitrypsin, 5.2 mg, was reacted with elastase, 0.87 mg, for 30 min at room temperature. Then, 0.61 mg of DFP in 0.033 ml of isopropanol was added to the reaction mixture, and the resultant solution was dialyzed against sodium phosphate buffer, 0.005 M, pH 5.5, which contained sodium chloride, 0.05 M, and applied to a column (0.7 x 13 cm) of DE-52 cellulose equilibrated with the same buffer. The proteins were eluted with a linear gradient of sodium chloride from 0.05 to 0.2 M (Fig. 3) . The SDS-PAG of the initial reaction mixture and peaks I and II thus obtained are shown in Fig. 2 .
The protein in peak I exhibited no catalytic activity against Ac-triAla-Me. Only peak I formed immunoprecipitin with antiserum to elastase, while both peaks I and II formed immunoprecipitates with antiserum to alpha-l-antitrypsin. The amount of complex in peak II, as illustrated by gel C of Fig. 2 , was apparently not high enough to produce an observable reaction with antiserum to elastase. Whereas peak I of Fig. 3 contained only the complex, peak II contained, in addition to a small amount of the complex, the form of alpha-l-antitrypsin previously described as inactive (11) . This protein was found by SDS-PAG electrophoresis (results not shown) to be present in the descending limb of peak II, producing a trailing shoulder. It can be observed as a band, in gel C in Fig. 2 , with a significantly higher mobility than that of native alpha-l-antitrypsin.
The elution profile shown by Fig. 3 is a typical one. It was found possible to obtain qualitatively the same results by fractionation of starting material prepared from 103 mg ofalpha-l-antitrypsin and 17 mg ofelastase on a 2.5 x 36 cm column of . The yield of purified complex in this instance was 47 mg.
An additional means of verifying the identity and characteristics of the complex was provided through the use of 125I-labeled elastase. The same reaction mixture for formation of the complex, as described above, was prepared for SDS-PAG electrophoresis with the labeled enzyme. The stained gel was first analyzed by scaning densitometry at 580 nm, then sectioned at 1 mm intervals for measurement of radioactivity. A gel that contained the purified complex was included for comparison in the densitometric analysis. The results showed that =95% of the radioactivity applied to the gel was contained in the complex band. A small peak of radioactivity that occurred at the mobility of native elastase amounted to 4.4% of the total radioactivity in the gel, although no peak of absorbance at 580 nm was detected at this mobility. This minor peak of radioactivity was in very good agreement with the active-site titration ofthe elastase employed (see Methods), whereby it was found to contain 5.5% catalytically inactive enzyme. The densitometric scan of the purified complex was identical in shape and location to the complex observed as a component ofthe reaction mixture, which suggests that it had not been changed during the steps employed to purify it.
The Mr of the complex was found to be about 74,100 and the amino-terminal residues by the dansyl chloride Alpha-l -Antitrypsin-Elastase Complex 1347 method were ser, asx, and val (Table I ). Because val is the amino-terminal residue of elastase and glx is the amino-terminal residue of alpha-l-antitrypsin, at least one (and possibly two) small peptide had apparently been cleaved from the amino-terminal end of the inhibitor during complex formation. Subsequent analysis of the amino-terminal sequence of the alpha-l-antitrypsin component (alpha-l-antitrypsin*) of the complex indicated that the ser was apparently in much higher concentration than the asx (vide infra). Thus, because the complex is a single component by SDS-PAG electrophoretic analysis (Fig. 2) , the major aminoterminal cleavage identifiable in alpha-l-antitrypsin on complete interaction with elastase is at an x-ser peptide linkage. Isolation and characterization of inactive alpha-lantitrypsin. The last one-half of the descending limb of peak II in Fig. 3 contained inactive alpha-l-antitrypsin. However, to obtain this modified form (11) of the inhibitor in the purified state and in more adequate quantity, alternative methods were used. Thus, a column of thiol Sepharose 4B (2 x 20 cm) to which 50 mg of alpha-l-antitrypsin has been bound (18) was reacted with 8.3 mg of elastase (3:1 molar ratio of bound inhibitor to enzyme) for 1 h, followed by addition and thorough mixing (by end-over-end rotation of the column) of 0.3 ml (5.53 mg) of DFP in isopropanol. After washing out unbound protein, elution with buffer that contained 5 mM L-cysteine-HCl was carried out to recover bound protein (complex, residual native alpha-iantitrypsin, and inactive alpha-l-antitrypsin). The latter mixture was then fractionated on a DE-52 column (2.6 x 18.5 cm) in the same manner as illustrated by Fig. 3 . The peaks obtained (Fig. 4) I), residual alpha-l-antitrypsin (peak II), and "inactive alpha-l-antitrypsin" (peak III), the latter occurring in the elution profile at the same position as the trailing shoulder of peak II (Fig. 3) . Approximately 5 mg of highly purified inactive alpha-l-antitrypsin (Fig. 5 ) was obtained. The only amino-terminal residue detected for material in peak III was glx (Table I) , the same residue as the amino-terminus of native alpha-lantitrypsin (14, 15) . As observed previously by us (11) and by others (12), the inactive inhibitor was incapable of inhibiting trypsin or elastase. The Mr of the purified inactive inhibitor was found to be 51,300 (Table I) . Splitting of the complex and recovery of the alpha-I-antitrypsin component (alpha-l-antitrypsin*) of the complex. A preliminary study was made with the purified complex to further investigate the conditions necessary to bring about its complete cleavage within a minimal time period. The complex in Tris-HCl buffer, 0.1 M, pH 7.6, containing sodium azide, 3 mM, was cleaved into its enzyme and inhibitor components (11) by adjusting the pH to 10, 11, 12, or 13 with appropriate amounts of 10 M sodium hydroxide (final sodium hydroxide concentration of m0.08, 0.10, 0.13, and 0.20 M, respectively) and incubation for 2 h at room temperature. 0.1 M DFP in isopropanol, was added in a 100:1 molar excess over the amount of enzyme before the pH was raised, and again after the 2-h incubation. The pH was then returned to 7.6 with concentrated hydrochloric acid. The extent of cleavage of the purified complex, and the nature of the cleavage products thus formed was examined on SDS-PAG (e.g., Fig. 6 , gel B). The complex which was cleaved at pH 12 showed two bands, one corresponding to a protein with an Mr of about 50,100 (alpha-l-antitrypsin*), and the other band to an elastase control. At pH values of 10 and 11, cleavage was incomplete, while at pH 13 an additional band between alpha-l-antitrypsin* and elastase was seen on the gels. Therefore, the cleavage of the complex was carried out at pH 12 for the isolation of alpha-1-antitrypsin*. A solution of 13.2 mg of isolated complex in Tris-HCG buffer, 0.1 M, pH 7.6, containing sodium azide, 3 mM, was raised to pH 12 with 10 M sodium hydroxide (final sodium hydroxide concentration of 0.13 M). The reaction mixture was incubated at room temperature for 2 h in the presence of a 100-fold molar excess ofDFP over enzyme. The pH was returned to 7.6 with HC1, and the solution was dialyzed extensively against sodium phosphate buffer, 0.005 M, pH 6.5, containing sodium chloride, 0.025 M, and DFP, 0.001 M. The dialyzed sample was applied to a chromatographic FIGURE 6 SDS-Polyacrylamide gel (7.5% acrylamide) electropherograms of fractions obtained during purification of alpha-l-antitrypsin*. A, Peak I of Fig. 3 (purified complex) ; B, complex after being split at pH 12 (starting material for chromatogram shown in Fig. 7) ; C, Peak I (elastase) of Fig. 7 ; D, Peak II (alpha-l-antitrypsin*) of Fig. 7 ; E, native alpha-lantitrypsin*; and F, native elastase. The arabic numbers to the right represent the mobilities ofthe complex (band 1), alpha-iantitrypsin (band 2), alpha-l-antitrypsin* (band 3); and elastase (band 4). All samples contained 35 ,ug of protein except for the complex, gel A, which had 20 Ag, and elastase, gel F, which had 15 ,ug. Anode at bottom. column (1.5 x 30 cm), containing DE-52 equilibrated with the same buffer, and elution was effected with a linear gradient from 0.025 to 0.125 M sodium chloride (Fig. 7) . Peak I contained free elastase, as d served immunoprecipitation again elastase, failure of formation of an in with antiserum to alpha-l-antitrypsin tropherogram shown in Fig. 6 , gel had no catalytic activity against the st Me, had amino-terminal val and an Mr ( Peak II contained alpha-l-antitrypsir by immunoprecipitation against anti antitrypsin, by failure of formation c cipitate with antiserum to elastase ar pherogram shown in Fig. 6 Fig. 6 , gel B. Porcine elastase, which has an approximate pKa (6) of inactivation of 11.4, is known to be unstable under alkaline conditions (40) .
Carboxy-terminal analysis of alpha-l-antitrypsin, inactive alpha-l-antitrypsin, and alpha-1-antitrypsin* It was considered important to the present studies to redetermine the carboxy-terminal residue of the inhibitor preparation being used, particularly as there are conflicting reports in the literature as to the carboxyterminal residue of human alpha-l-antitrypsin (5, (41) (42) (43) (44) . Thus, alpha-l-antitrypsin (20-nmol quantities) was reacted with carboxypeptidase Y at an enzyme:substrate ratio of 1:100 (weight/weight) for periods of Thus it was concluded that lys was the carboxynl)
terminal residue of the alpha-l-antitrypsin preparation on of alpha-i-anti-used in these studies (Table I) . That either lys (41, 42) dicated by diagonal or leu (5, 43, 44) (Table I) .
er, and dissolved s found to exhibit DISCUSSION ity as elastase on Lower molecular weight alpha-l-antitrypsin-elastase 'al (Table I ). The complexes than that described in these studies have weak appearance been reported previously (11, 12) . These complexes were seen with higher molar ratios of enzyme to in-K. Chan, University hibitor, and they may be formed by degradation of the higher molecular weight complexes by elastase mole-cules which were transiently diverted to the cleavage site which results in inactive alpha-l-antitrypsin. In addition, because a part of the alpha-l-antitrypsin is inactivated by elastase, higher molar ratios of inhibitor to elastase than the ratio necessary to inhibit trypsin, as seen from the data illustrated in Fig. 1 , are necessary to prevent the occurrence of free active elastase and the degradation of the high molecular weight complexes. No complex has been observed with a higher mass ratio than the sum of the molecular weights of the two reactants, which indicates that alpha-l-antitrypsin does not form a complex that contains more than one elastase molecule. The data presented show that when alpha-l-antitrypsin is combined with elastase with a large excess of inhibitor, more than one reaction takes place (Fig. 8) .
The elastase hydrolyzes the alpha-l-antitrypsin at a G)
leu-y peptide bond near the carboxy-terminal end of the inhibitor, which results in a molecule with an Mr of_51,300 (inactive alpha-l-antitrypsin) which has an unchanged amino-terminus, and which is no longer capable of inhibiting enzymes. However, it is proposed (Fig. 8) Table I .
Alpha-l -Antitrypsin-Elastase Complextide linkage forces the same enzyme molecule to become complexed with the molecule of alpha-l-antitrypsin thus cleaved. A stable bond then forms at the same leu-y peptide linkage which would otherwise have been cleaved to produce free, inactive alpha-l-antitrypsin.
The alpha-l-antitrypsin-trypsin complex is also alkaline labile. We have demonstrated that, when the hydrolysis of the complex is catalyzed by 180H-, the new carboxy-terminal lysine residue becomes labeled with 180 (45) . These studies conform to the known distribution of oxygens which occurs during the base-catalyzed hydrolysis of acyl esters (46) (47) (48) and which would be likely to occur if the complex were an acyl ester or if an acyl intermediate formed during the base-catalyzed hydrolysis of a tetrahedral adduct. The alkaline lability of the alpha-l-antitrypsin-elastase complex makes a similar mechanism likely.
In conclusion, there may be only two major sites in alpha-l-antitrypsin which are attacked by elastase. If the site near the carboxy-terminal end is attacked first, the bond is cleaved. However, if the amino-terminal cleavage occurs first, then the inhibitor molecule undergoes a change which causes the elastase enzyme molecule to bind tightly in a stable complex at the same site near the carboxy-terminal end which would otherwise have led to a "nonproductive" cleavage and the formation ofinactive alpha-l-antitrypsin. While this hypothesis is a logical interpretation of the present observations, the observed covalent changes in the inhibitor molecule do not necessarily prove that the initial removal of the amino-terminal peptide is an activation process. Further studies are under way in this laboratory to isolate and characterize the peptides released from alpha-i-antitrypsin, as postulated in Fig. 8 .
This approach, and the prospect oflabeling the apparent active-site leu residue in the inhibitor with 80H-as in the previous studies on alpha-l-antitrypsin-trypsin complex formation (45) , would be of benefit in further establishing the molecular events in the inhibition of serine proteases by alpha-l-antitrypsin.
